CL2017000665A1 - Formulación - Google Patents

Formulación

Info

Publication number
CL2017000665A1
CL2017000665A1 CL2017000665A CL2017000665A CL2017000665A1 CL 2017000665 A1 CL2017000665 A1 CL 2017000665A1 CL 2017000665 A CL2017000665 A CL 2017000665A CL 2017000665 A CL2017000665 A CL 2017000665A CL 2017000665 A1 CL2017000665 A1 CL 2017000665A1
Authority
CL
Chile
Prior art keywords
formulation
parasiticiated
water
homogenic
solubilizer
Prior art date
Application number
CL2017000665A
Other languages
English (en)
Inventor
Stian Brekke
Marius Karlsen
Mari Skurdal Grongstad
Rachmilla Souhoka Andersen
Knut Egil Lokling
Elin Aksnes
Original Assignee
Pharmaq As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=51869213&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2017000665(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pharmaq As filed Critical Pharmaq As
Publication of CL2017000665A1 publication Critical patent/CL2017000665A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

<p>LA PRESENTE INVENCIÓN SE REFIERE A UNA FORMULACIÓN PARASITICIDA. LA FORMULACIÓN NO ES TOXICA A LOS PECES CUANDO SE ADMINISTRA PER INYECCIÓN INTRAPERITONEAL. LA FORMULACIÓN ES UNA SOLUCIÓN PARASITICIDA NO ACUOSA HOMOGÉNEA. LA FORMULACIÓN COMPRENDE: A.-UN POLÍMERO HIDROFÍLICO; Y/O,  B.-UN SOLVENTE POLAR NO ACUOSO, PRESENTE EN LA FORMULACIÓN UNA CANTIDAD DE 5-40% EN PESO, Y UN SOLUBILIZADOR.</p>
CL2017000665A 2014-09-19 2017-03-17 Formulación CL2017000665A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1416633.4A GB201416633D0 (en) 2014-09-19 2014-09-19 Formulation
GBGB1511301.2A GB201511301D0 (en) 2014-09-19 2015-06-26 Formulation

Publications (1)

Publication Number Publication Date
CL2017000665A1 true CL2017000665A1 (es) 2017-11-10

Family

ID=51869213

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2017000665A CL2017000665A1 (es) 2014-09-19 2017-03-17 Formulación

Country Status (9)

Country Link
EP (1) EP3193856B1 (es)
CN (1) CN107106691B (es)
CA (1) CA2961592C (es)
CL (1) CL2017000665A1 (es)
DK (2) DK3193856T3 (es)
ES (1) ES2890678T3 (es)
GB (2) GB201416633D0 (es)
HR (1) HRP20211558T1 (es)
WO (1) WO2016042154A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111387222A (zh) * 2019-09-12 2020-07-10 浙江海洋大学 一种纺锤水蚤消除剂
EP4680241A1 (en) 2023-03-13 2026-01-21 Virbac Arylaminobenzamide or isoxazoline compounds for use in controlling a parasite infestation on a fish
DK202400844A1 (en) * 2023-09-25 2025-04-08 Zoetis Services Llc Use of hexaflumuron to control parasitic infections in farmed and wild fish

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH687732A5 (de) * 1994-06-09 1997-02-14 Ciba Geigy Ag Verfahren zur Bekaempfung von Insekten.
CN101637172B (zh) * 2009-06-12 2013-03-27 深圳诺普信农化股份有限公司 一种虱螨脲和虫酰肼杀虫螨组合物
CA2879477A1 (en) * 2012-07-27 2014-01-30 Novartis Ag New treatment of fish with a nanosuspension of lufenuron or hexaflumuron

Also Published As

Publication number Publication date
CA2961592A1 (en) 2016-03-24
EP3193856A1 (en) 2017-07-26
EP3193856B1 (en) 2021-08-11
WO2016042154A1 (en) 2016-03-24
CN107106691A (zh) 2017-08-29
ES2890678T3 (es) 2022-01-21
GB201416633D0 (en) 2014-11-05
GB201511301D0 (en) 2015-08-12
DK179602B1 (en) 2019-02-26
DK3193856T3 (da) 2021-09-06
HRP20211558T1 (hr) 2022-01-07
DK201770271A1 (en) 2017-05-01
CA2961592C (en) 2019-05-21
CN107106691B (zh) 2021-04-20

Similar Documents

Publication Publication Date Title
CR20160419A (es) Nuevos compuestos biciclicos
CR20170099A (es) Pirrolobenzodiazepinas y conjugados de anticuerpos-disulfuro de las mismas
AR104725A1 (es) Composiciones surfactantes y detergentes que contienen glicerina etoxilada
CL2017003402A1 (es) Derivado de glucagón y una composición que comprende un conjugado de acción prolongada del mismo
MX377610B (es) Agonistas del receptor de glucagon.
CR20150436A (es) Nuevos octahidro-pirrolo[3,4-c]-pirrol y -piridina-fenilo
BR112017003568A2 (pt) composição detergente líquida para lavagem de roupas
EA201692219A1 (ru) Способы получения противовирусных соединений
MX390001B (es) Composiciones de bebida lista para beber estables que comprende agentes activos lipofilos.
AR102658A1 (es) Composición para el tratamiento de telas
MX2016014890A (es) Agonistas del receptor de apelina (apj) y usos de los mismos.
CR20180072A (es) Nuevos compuestos biciclicos como inhibidores de atx
CR20150440A (es) Nuevos derivados de piridina
AR100373A1 (es) Composición detergente líquida antimicrobiana para lavandería
CO2018004573A2 (es) Derivados de fenilo como agonistas del receptor 2 de cannabinoides
CL2017000640A1 (es) Nuevos activadores de la guanilato ciclasa soluble y su uso
CR20150210A (es) Nuevos derivados de pirazina como agonistas receptores de cb2
MX2018001046A (es) Barra de limpieza de bajo contenido de materia grasa total (mgt).
EA201691982A1 (ru) 5,6-дизамещенные пиридин-2-карбоксамиды в качестве агонистов каннабиноидных рецепторов
UY36500A (es) Composiciones del inhibidor de la nitrificación y métodos de preparación de las mismas
CR20150511A (es) Nuevos derivados de purina
MX2016000219A (es) Compuestos neurotransmisores de dihidroxifenilo, composiciones y metodos.
EP3504185A4 (en) NEW SUBSTITUTED N&#39;-HYDROXYCARBAMIMIDOYL-1,2,5-OXADIAZOLE COMPOUNDS AS INHIBITORS OF INDOLEAMINE-2,3-DIOXYGENASE (IDO)
EA201990810A1 (ru) Композиция, содержащая соль ацилглутамата в качестве основного поверхностно-активного вещества или основного анионного поверхностно-активного вещества и специфические структурирующие полимеры
MX2015016300A (es) Polvos saborizantes chapados.